sciclone pharmaceuticals inc
(SCLN:Consolidated Issue Listed on NASDAQ Global Select )
Chief Executive Officer, President and Director, NovaMed Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 8 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. Mark Lotter served as the Chief Executive Officer of China Operations at SciClone Pharmaceuticals, Inc., from April 2011 to December 14, 2012. Mr. Lotter serves as the Chief Executive Officer and President of NovaMed Pharmaceuticals Inc. Prior to founding NovaMed, Mr. Lotter served as Vice President, Commercial Operations of AstraZeneca China. He was largely responsible for turning AstraZeneca to the largest prescription based multinational in China. He served as ...
950 Tower LanePhone: 650-358-3456
Foster City, California 94404
Board Members Memberships*
Chief Executive Officer, President and Director
Former Chief Executive Officer of China Operations and Director
The University of KwaZulu-Natal
University of South Africa
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|